Apimeds Pharmaceuticals US, Inc. Liquidation Value Calculator
Apimeds Pharmaceuticals US, Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 77 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$6.99M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$6.99M | USD | ||
| current_liabilities | ||||
| Other Accrued Liabilities Current total OtherAccruedLiabilitiesCurrent |
$3,657 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$1.09M | USD | ||
| liabilities_total | ||||
| Liabilities total | $1.09M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
12.6M | shares | ||
Unmapped Tags (69)
| Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent | $567,633 | USD | ||
| Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent | $567,633 | USD | ||
| Additional Paid In Capital AdditionalPaidInCapital | $17.27M | USD | ||
| Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued | $161,554 | USD | ||
| Assets Assets | $9.25M | USD | ||
| Assets Current AssetsCurrent | $9.09M | USD | ||
| Cash FDIC Insured Amount CashFDICInsuredAmount | $250,000 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $100.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $12.58M | shares | ||
| Common Stock Value CommonStockValue | $125,760 | USD | ||
| Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount | $273,324 | USD | ||
| Investment Income Interest InvestmentIncomeInterest | $71,676 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $9.25M | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $10.00M | shares | ||
| Prepaid Insurance PrepaidInsurance | $344,990 | USD | ||
| Property Plant And Equipment Net PropertyPlantAndEquipmentNet | $34,188 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-9.24M | USD | ||
| Stockholders Equity StockholdersEquity | $8.16M | USD | ||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | $42,674 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | $6.98M | USD | ||
| Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance | $42,283 | shares | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | $-23,558 | USD | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | $2.22M | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $12.13M | USD | ||
| Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities | $-35,909 | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-5.11M | USD | ||
| Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment | $35,909 | USD | ||
| Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock | $11.95M | USD | ||
| Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt | $3.00M | USD | ||
| Proceeds From Notes Payable ProceedsFromNotesPayable | $250,000 | USD | ||
| Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt | $17,400 | USD | ||
| Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt | $93,800 | USD | ||
| Share Based Compensation ShareBasedCompensation | $234,727 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | $750,000 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | $372,604 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | $5 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | $496,179 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $709,871 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | $3 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | $2 | USD/shares | ||
| Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense | $372,805 | USD | ||
| Accretion Expense AccretionExpense | $39,833 | USD | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $961,121 | shares | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-0 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-0 | USD/shares | ||
| Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements | $0 | pure | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $3.60M | USD | ||
| Interest Expense Nonoperating InterestExpenseNonoperating | $67,387 | USD | ||
| Net Income Loss NetIncomeLoss | $-4.85M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $26,666 | USD | ||
| Operating Expenses OperatingExpenses | $4.87M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-4.87M | USD | ||
| Other Prepaid Expense Current OtherPrepaidExpenseCurrent | $154,355 | USD | ||
| Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent | $2.10M | USD | ||
| Prepaid Expense Noncurrent PrepaidExpenseNoncurrent | $129,740 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $1.27M | USD | ||
| Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent | $18,250 | USD | ||
| Accrued Professional Fees Current AccruedProfessionalFeesCurrent | $193,377 | USD | ||
| Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred | $1 | USD | ||
| Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1 | $297,133 | shares | ||
| Depreciation Depreciation | $1,721 | USD | ||
| Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants | $-22,377 | USD | ||
| Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions | $1.70M | USD | ||
| CommonStockConvertibleConversionPriceDecrease CommonStockConvertibleConversionPriceDecrease | $3 | USD/shares | ||
| WarrantExercisePriceDecrease WarrantExercisePriceDecrease | $5 | USD/shares |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.